Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001140361-25-046189
Filing Date
2025-12-19
Accepted
2025-12-19 16:05:42
Documents
1
Effectiveness Date
2025-12-19

Document Format Files

Seq Description Document Type Size
1 15-12G ef20061504_15-12g.htm 15-12G 11628
  Complete submission text file 0001140361-25-046189.txt   12689
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-38944 | Film No.: 251587523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)